| Authors: |
Appelman EM; Department of Medicine - Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands; Department of Medicine - Division of Oncology, Leiden University Medical Center, Leiden, the Netherlands., Martens ESL; Department of Medicine - Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands., Burger DM; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands, & Global DDI Solutions, Utrecht, the Netherlands., van Gelder T; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands., van der Hulle T; Department of Medicine - Division of Oncology, Leiden University Medical Center, Leiden, the Netherlands., van Rein N; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands., Klok FA; Department of Medicine - Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: f.a.klok@LUMC.nl. |